- Home
- NSPR vs IAE Comparison
NSPR vs IAE Comparison
Compare NSPR & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- IAE
- Stock Information
- Founded
- NSPR 2005
- IAE 2007
- Country
- NSPR United States
- IAE United States
- Employees
- NSPR N/A
- IAE N/A
- Industry
- NSPR Medical/Dental Instruments
- IAE Trusts Except Educational Religious and Charitable
- Sector
- NSPR Health Care
- IAE Finance
- Exchange
- NSPR Nasdaq
- IAE Nasdaq
- Market Cap
- NSPR 79.7M
- IAE 65.2M
- IPO Year
- NSPR N/A
- IAE N/A
- Fundamental
- Price
- NSPR $2.60
- IAE $6.27
- Analyst Decision
- NSPR Strong Buy
- IAE
- Analyst Count
- NSPR 2
- IAE 0
- Target Price
- NSPR $4.75
- IAE N/A
- AVG Volume (30 Days)
- NSPR 48.2K
- IAE 46.3K
- Earning Date
- NSPR 05-09-2025
- IAE 01-01-0001
- Dividend Yield
- NSPR N/A
- IAE 10.21%
- EPS Growth
- NSPR N/A
- IAE N/A
- EPS
- NSPR N/A
- IAE N/A
- Revenue
- NSPR $7,009,000.00
- IAE N/A
- Revenue This Year
- NSPR $28.93
- IAE N/A
- Revenue Next Year
- NSPR $172.18
- IAE N/A
- P/E Ratio
- NSPR N/A
- IAE N/A
- Revenue Growth
- NSPR 12.96
- IAE N/A
- 52 Week Low
- NSPR $2.07
- IAE $5.31
- 52 Week High
- NSPR $3.80
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- NSPR 49.84
- IAE 61.01
- Support Level
- NSPR $2.40
- IAE $6.19
- Resistance Level
- NSPR $2.79
- IAE $6.33
- Average True Range (ATR)
- NSPR 0.16
- IAE 0.09
- MACD
- NSPR 0.01
- IAE 0.03
- Stochastic Oscillator
- NSPR 60.42
- IAE 87.76
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.